Digital Therapeutics

Expanding Product Portfolios Through Technology Integration

September 14, 2023 - The biotechnology and pharmaceutical industries have long been at the forefront of technological innovation, leveraging cutting-edge advancements to improve healthcare outcomes and enhance product portfolios.   In an era where digital transformation and internet technology are shaping the future of every sector, biotech and pharma companies must embrace these trends to stay...

Read More


More Articles

Challenges of Improving Access to Digital Therapeutics in Healthcare

by Alivia Kaylor

In an increasingly digital landscape, digital therapeutics (DTx) are quickly transforming the healthcare industry. Still, developers of DTx face numerous challenges, such as encouraging adoption, proving clinical efficacy, and...

New Toolkit Supports Digital Endpoints in Drug Development

by Samantha McGrail

The Digital Medicine Society (DiMe), Anthem, Biogen, Eli Lilly & Company, Evidation, Janssen, Merck, Pfizer, and Savvy Co-op recently launched a toolkit of resources to support organizations...

Medidata, Labcorp Collaborate to Boost Digital Biomarker Discovery

by Samantha McGrail

Medidata and Labcorp Drug Development recently entered into an agreement to expand decentralized clinical trial capabilities and digital biomarker discovery. The companies will leverage Medidata...

Role of Digital Therapeutics in Chronic Disease Management

by Samantha McGrail

Digital therapeutics present potential solutions for chronic diseases management, ranging from Alzheimer’s disease, type 2 diabetes, congestive heart failure, and cancer. The same technologies...

Eli Lilly Takes on Digital Diabetes Care Management

by Samantha McGrail

Eli Lilly and Company recently signed strategic international agreements with four companies to advance connected solutions and streamline diabetes care management for individuals living with the...

MedRhythm Begins Trial to Study Digital Therapeutics for Stroke

by Samantha McGrail

Digital therapeutics company, MedRhythms, recently announced the launch of a clinical trial to study the company’s digital therapeutics trial for stroke, MR-010. In partnership with UMass...

NIH Launches Trial to Test Immune Modulator Drugs for COVID-19

by Samantha McGrail

NIH recently launched a Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized COVID-19 patients.  The trial, which is part of...

Major Pharma Companies Support Global Access to COVID-19 Vaccine

by Samantha McGrail

AstraZeneca, Gilead, Johnson & Johnson, and other major pharmaceutical companies recently backed efforts to expand global access to COVID-19 vaccines, diagnostics, and therapeutics. In a joint...

Roche Launches Quantitative COVID-19 Antibody Test

by Samantha McGrail

Roche recently announced the launch of its new COVID-19 antibody test, Elecsys Anti-SARS-CoV-2 S, for markets accepting the CE Mark. The serology test will measure the number of antibodies to the...

Harvard Launches Spinout to Address mRNA, CRISPR Challenges

by Samantha McGrail

Harvard University recently launched Vesigen Therapeutics, which will address the challenges of delivering RNAi, mRNA, and CRISPR technologies to intracellular targets in specific tissues of...

Roche to Co-Develop Investigational Therapy for RET-Altered Cancers

by Samantha McGrail

Roche and Blueprint Medicines Corporation recently signed an agreement to provide exclusive rights to Roche for global co-development and commercialization of an investigational therapy for patients...

FDA Oks Botox As a Biologic for Pediatric Urology Patients

by Samantha McGrail

Allergan, an AbbVie company, recently announced that the FDA accepted its supplemental biologics license application (sBLA) to expand BOTOX prescribing information for bladder (detrusor) overactivity...

AbbVie, Genmab Team Up for Antibody Therapeutics for Cancer

by Samantha McGrail

AbbVie and Genmab recently signed a broad collaboration agreement to jointly develop and commercialize Genmab’s three early-stage investigational antibody therapeutics for cancer.  Genmab...

FDA Rejects Bristol Myers Cell Squibb’s CAR T-Cell Therapy

by Samantha McGrail

FDA recently issued a Refusal to File letter to Bristol Myers Squibb (BMS) and Bluebird Bio regarding the Biologics License Application (BLA) for idecabtagene vicleucel, a chimeric antigen receptor...

Phase 3 Trial Finds Positive Results for Microbiome Treatment

by Samantha McGrail

Rebiotix and Ferring Pharmaceuticals recently announced positive preliminary findings from their ongoing pivotal Phase 3 trial of the investigational microbiome therapy treatment, RBX2660. The...

Roche Launches Serology Test to Uncover COVID-19 Antibodies

by Samantha McGrail

Roche recently announced the development of a serology test to detect antibodies in individuals who have been exposed to COVID-19.  For more coronavirus updates, visit our resource page,...

Recent Articles